𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serotonergic modulation of response inhibition and re-engagement? Results of a study in healthy human volunteers

✍ Scribed by Barbara Drueke; Maren Boecker; Sonja Schlaegel; Olaf Moeller; Christoph Hiemke; Gerhard Gründer; Siegfried Gauggel


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
131 KB
Volume
25
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Objective

Cognitive functions dependent on the prefrontal cortex, such as the ability to suppress behavior (response inhibition) and initiate a new one (response re‐engagement) is important in the activities of daily life. Central serotonin (5‐HT) function is thought to be a critical component of these cognitive functions. In recent studies, 5‐HT failed to affect stop‐signal reaction time (SSRT), a fundamental process in behavioral inhibition. We were interested if response inhibition and re‐engagement are influenced through central 5‐HT activity as mediated via the 5‐HT transporter.

Methods

Here, using a stop‐change task, we investigated the effects of acute and repeated treatment with 10 mg escitalopram, a selective 5‐HT reuptake inhibitor, in 36 healthy human volunteers on response inhibition and re‐engagement in a randomized, double‐blind, placebo‐controlled study with cross‐over design.

Results

Results do not show an influence of escitalopram on response inhibition or response re‐engagement as we did not find differences in SSRT or change reaction time (CRT).

Conclusions

These findings support the results of previous studies suggesting that 5‐HT is not critical in inhibition of already initiated responses and response re‐engagement. We hypothesize that results are due to different forms of behavioral inhibition and 5‐HT may critical to other forms. Copyright © 2010 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


Gd-DTPA2–-enhanced MRI of femoral knee c
✍ Carl J. Tiderius; Lars E. Olsson; Hans de Verdier; Peter Leander; Olle Ekberg; L 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

## Abstract The negatively charged contrast agent Gd‐DTPA^2–^ distributes inversely to the cartilage fixed charged density. This enables structural cartilage examinations by contrast‐enhanced MRI. In line with the development of a clinically applicable protocol for such examinations, this study des

Pharmacological modulation of the bOLD r
✍ Mohammad S. Asghar; Adam E. Hansen; Simon Pedersen; Henrik B.W. Larsson; Messoud 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

## Abstract ## Purpose: To examine the effect of acetazolamide, known to increase cerebral blood flow (CBF) and glyceryl trinitrate (GTN), known to increase cerebral blood volume (CBV) on the blood oxygenation level‐dependent (BOLD) response in humans using 3 T magnetic resonance imaging (MRI), an

A placebo-controlled dose response study
✍ Dr. U. Ganzinger; H. Bachmayer; E. Liehl; J. J. Martindale; F. Hamilton; Dr. E. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

A live cold-recombinant influenza B virus vaccine (RB77) was given intranasally in a placebo-controlled, double blind study to volunteers in dosages of 10(7.9) EID50/ml, 10(7.25) EID50/ml, 10(5.7) EID50/ml. The tolerability, safety, and immunogenicity of the vaccine were investigated. No revertant v

Effects of DRD2 and CYP2D6 genotypes on
✍ Euitae Kim; Kyung-Sang Yu; Joo-Youn Cho; Yong-Wook Shin; So Young Yoo; Young You 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

The aim of the present study was to evaluate the effects of polymorphisms in dopamine D2 receptor (DRD2) and cytochrome P450 (CYP) 2D6 genes on delta EEG power response to aripiprazole in healthy male volunteers. Seventeen volunteers were recruited according to the DRD2 Taq1A genotype, and separated

Simultaneous determination of metformin
✍ Guo-ping Zhong; Hui-chang Bi; Shufeng Zhou; Xiao Chen; Min Huang 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

## Abstract A rapid and sensitive liquid chromatography/tandem mass spectrometry (LC/MS/MS) method was developed and validated to simultaneously determine gliclazide and metformin in human plasma using huperzine A as the internal standard (IS). After acetonitrile‐induced protein precipitation of th